首页> 外国专利> Allogeneic hematopoietic stem cell transplantation method

Allogeneic hematopoietic stem cell transplantation method

机译:同种异体造血干细胞移植方法

摘要

Described herein are compositions and methods useful for the treatment of depletion of CD117+ or CD45+ cells and, inter alia, various hematopoietic diseases, metabolic disorders, cancer, and autoimmune diseases. The compositions and methods described herein can be used to treat a disorder, for example, by depleting a population of CD117+ or CD45+ cancer cells or autoimmune cells. The compositions and methods described herein may also be used to improve engraftment of allogeneic hematopoietic stem cell transplants by preparing patients for allogeneic hematopoietic stem cell transplantation therapy and selectively depleting endogenous hematopoietic stem cells prior to transplantation procedures. can
机译:本文描述的是用于治疗CD117 +或CD45 +细胞的耗尽的组合物和方法,并且尤其是各种造血疾病,代谢障碍,癌症和自身免疫疾病。本文所述的组合物和方法可用于治疗病症,例如,通过耗尽CD117 +或CD45 +癌细胞或自身免疫细胞的群体。本文所述的组合物和方法还可用于通过制备同种异体造血干细胞移植治疗和在移植程序之前选择性地耗尽内源性造血干细胞来改善同种异体造血干细胞移植物的植入。能够

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号